by jlohrconsulting | Sep 1, 2025 | Uncategorized
Pain Med. 2025 Sep 1:pnaf119. doi: 10.1093/pm/pnaf119. Online ahead of print. ABSTRACT OBJECTIVE: The transition from hospital to home is a high-risk period for medication errors, particularly in patients receiving opioids. We constructed and validated a Medication...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
J Cancer Surviv. 2025 Sep 1. doi: 10.1007/s11764-025-01885-3. Online ahead of print. ABSTRACT PURPOSE: Cancer-related cognitive impairment (CRCI) refers to cognitive changes described by cancer patients. While subjective cognitive difficulties in survivors are well...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
Fish Physiol Biochem. 2025 Sep 1;51(5):155. doi: 10.1007/s10695-025-01574-z. ABSTRACT The use of anaesthetics has become extremely important in promoting responsible welfare practices in aquaculture and research. However, adverse reactions and side effects have been...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
Eur Spine J. 2025 Sep 1. doi: 10.1007/s00586-025-09247-4. Online ahead of print. ABSTRACT BACKGROUND: Opioid-free analgesia is critical in pediatric patients with complex comorbidities to avoid adverse effects, such as respiratory depression. Patients with tethered...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
Nervenarzt. 2025 Sep 1. doi: 10.1007/s00115-025-01873-z. Online ahead of print. ABSTRACT In the ICD-10 the developmental disorders are categorized under three different chapters: F7 for mental retardation, F8 for developmental disorders and F9 for disorders with onset...
by jlohrconsulting | Sep 1, 2025 | Uncategorized
Arch Toxicol. 2025 Sep 1. doi: 10.1007/s00204-025-04160-7. Online ahead of print. ABSTRACT Alzheimer’s disease (AD), a neurodegenerative “memory killer” demanding urgent global intervention, has long been shrouded in mystery regarding its core...
Recent Comments